Where to Give a Steroid Shot for Best Results

The best place to give a steroid shot depends entirely on what you’re treating, but the evidence consistently shows that precise placement into the right tissue layer is the single biggest factor in how well the injection works. A shot that lands even a few millimeters off target can miss the joint space, pool in subcutaneous fat, or fail to reach the inflamed nerve root. Across joints, muscles, and soft tissues, research has clarified which anatomical approaches, injection angles, and guidance methods produce the best outcomes.

Intramuscular Injections and Why the Gluteal Site Matters

When a steroid is injected into muscle for systemic effects, the two most common targets are the gluteal muscles (the buttocks) and the deltoid (upper arm). Research on oil-based steroid esters in men found that injecting into the gluteal muscle produced greater bioavailability and stronger physiological effects compared with the deltoid, and that smaller injection volumes outperformed larger ones.¹ The gluteal muscles are simply thicker and have better blood supply for absorbing medication, which is why they remain the default for most intramuscular steroid injections.

Within the gluteal region, though, not all spots are equal. The traditional site, the dorsogluteal (upper outer quadrant of the buttock), has been taught in nursing and medical schools for decades. But the ventrogluteal site, located more on the side of the hip, consistently performs better. A meta-analysis of nine studies found that ventrogluteal injections produced significantly less pain, less bleeding, and less bruising compared with the traditional dorsogluteal site.² Part of the reason is anatomy: the ventrogluteal site has thicker underlying muscle and thinner subcutaneous fat. Ultrasound measurements in older adults confirmed that muscle thickness at the ventrogluteal site averaged about 40 mm compared to roughly 26 mm at the dorsogluteal site, making it easier for a standard needle to actually reach muscle rather than depositing the medication in fat.³

The dorsogluteal site also sits near the sciatic nerve, adding a small but real risk of nerve injury that the ventrogluteal site avoids entirely. Despite all this evidence, many clinicians still default to the dorsogluteal site out of habit. If you’re getting a systemic steroid injection in the buttock, it is reasonable to ask whether the ventrogluteal site is being used.

How Body Size Changes the Equation

Your body mass index and overall body composition have a direct effect on whether an intramuscular injection actually reaches the muscle. A study examining gender, BMI, and body shape found that women, people with higher BMI, and those with a rounder body type had significantly thicker subcutaneous fat at both gluteal sites, which increased the likelihood that the needle would deposit medication into fat rather than muscle.⁴ A separate study confirmed a significant correlation between BMI and the depth of subcutaneous fat overlying the gluteal muscles on both sides.⁵

This is not just an academic point. A steroid meant for slow, sustained release from muscle tissue will behave differently if it ends up in fat, potentially absorbing more erratically or causing local complications like skin thinning. For people with higher BMI, the ventrogluteal site offers a meaningful advantage because its subcutaneous fat layer is thinner relative to the dorsogluteal site. Clinicians sometimes also choose longer needles for larger patients, though needle length decisions are best left to the provider based on individual anatomy.

Knee Injections and the Question of Approach

The knee is one of the most commonly injected joints for steroid therapy, typically for osteoarthritis or inflammatory flares. Three main approaches exist: superolateral (from the outer-upper aspect of the kneecap), anteromedial (from the inner front), and anterolateral (from the outer front). When researchers pooled data across studies, the superolateral approach was the most accurate for getting the needle into the joint space without imaging guidance, hitting the mark about 87% of the time. The medial and anterolateral approaches were less reliable, with accuracy closer to 64-70%.⁶ Reviews have noted that inaccurate placement happens in up to one in five knee injections overall.⁷

Here is the interesting part: even though the superolateral approach lands in the joint space more reliably, a randomized trial comparing all three approaches found no significant differences in pain relief or functional improvement at one and four weeks after injection.⁸ Procedural discomfort was similar across all three approaches too. This suggests that as long as the injection gets into the joint, the specific entry point matters less than simply getting accurate placement.

Ultrasound guidance tilts accuracy dramatically in the clinician’s favor. A systematic review of randomized trials found that ultrasound-guided knee injections were more accurate than blind injections in every study examined.⁹ Another review quantified the gap: ultrasound-guided injections reached the joint space about 96% of the time versus roughly 78% for anatomically guided (blind) injections.¹⁰ That accuracy gap translated into better patient-reported outcomes and greater cost-effectiveness, since a missed injection means wasted medication and a return visit. A more recent systematic review confirmed these findings, supporting that ultrasound guidance produces both greater accuracy and better clinical results than landmark-based techniques.¹¹

Shoulder Injections and Where They Should Land

Shoulder steroid injections present a unique challenge because the shoulder is not one simple joint space. There are two main targets: the glenohumeral joint (the actual ball-and-socket joint) and the subacromial space (the area above the rotator cuff tendons, below the bony arch of the shoulder). Where the injection should go depends on the diagnosis.

For rotator cuff tendinitis, the subacromial space is the primary target. A meta-analysis found that subacromial corticosteroid injections for rotator cuff tendinitis had a strong treatment effect, with patients about three times more likely to improve compared with controls. Intra-articular (glenohumeral) injections for the same condition did not reach statistical significance.¹² The logic tracks with the anatomy: rotator cuff tendons pass through the subacromial space, so delivering medication directly there makes more sense than injecting into the joint below.

For impingement syndrome with stiffness, a randomized trial found that injections into the glenohumeral joint produced faster early improvement in range of motion at three weeks compared to subacromial injections. By 13 weeks, however, both groups had improved to similar levels.¹³ For adhesive capsulitis (frozen shoulder), a meta-analysis comparing intra-articular and subacromial injections found that outcomes were largely similar, with only minor short-lived differences in pain scores at two to three weeks. One notable finding: subacromial injection had the advantage of avoiding certain adverse reactions from the corticosteroid, particularly large fluctuations in blood sugar levels.¹⁴ That detail matters for people with diabetes, who need to be especially careful about steroid-related blood glucose spikes.

Epidural Steroid Injections for Spinal Pain

Epidural steroid injections for disc herniations and radiculopathy can be delivered through three routes: transforaminal (from the side, targeting a specific nerve root), interlaminar (from the back, between vertebral arches), and caudal (from the tailbone, entering the bottom of the spinal canal). These are not interchangeable. A study comparing all three for lumbar disc herniations found that the transforaminal route was significantly more effective than either caudal or interlaminar routes, with about 90% of patients showing improvement at one year compared with roughly 74-78% for the other approaches.¹⁵

The tradeoff is risk. A review of all three approaches noted that the transforaminal route provides the most targeted delivery to affected nerve roots but carries higher risks of complications including nerve injury or vascular compromise. The interlaminar approach offers broader spread of medication with simpler technique but less precision. The caudal approach is generally the safest but delivers medication least precisely and is typically reserved for patients with altered spinal anatomy or prior lumbar surgery.¹⁶ A pain specialist will choose the route based on what structure is causing the pain, the patient’s anatomy, and their surgical history. These injections are always performed under fluoroscopic or CT guidance.

Wrist and Hand Injections

Carpal tunnel syndrome is one of the most common conditions treated with a local steroid injection, and here the evidence strongly favors injecting locally rather than taking oral steroids. A Cochrane review found that local corticosteroid injection produced significantly greater improvement compared with oral corticosteroid out to three months.¹⁷ A systematic review confirmed moderate evidence favoring local injection over systemic corticosteroid in the short term.¹⁸

For carpal tunnel specifically, the injection needs to reach the space around the median nerve within the carpal tunnel without actually hitting the nerve. Ultrasound guidance makes a clear difference here. A meta-analysis found that ultrasound-guided injections significantly reduced symptom severity and improved functional scores compared with anatomically guided (blind) injections, and the rate of nerve injury was substantially lower in the ultrasound group.¹⁹ A randomized trial found that symptoms of median nerve irritation occurred in about 14% of patients receiving landmark-based injections but only 2% of those receiving ultrasound-guided injections.²⁰

Even the angle of approach matters. A study comparing radial (thumb-side) versus ulnar (pinky-side) in-plane approaches for ultrasound-guided carpal tunnel injections found that the radial approach produced greater pain reduction and better ultrasound-measured improvements in nerve size.²¹

For De Quervain’s tenosynovitis, a painful condition affecting the tendons on the thumb side of the wrist, the injection is placed between two specific tendons a few centimeters above the wrist bone.²² Ultrasound guidance proves valuable here too, because the tendon compartment sometimes has subdivisions that are invisible without imaging. A study of 50 patients found that when subcompartments were present, two separate injections into each subcompartment produced better improvement than a single injection.²³

Hip Injections and Deep Joints

The hip joint sits deep beneath layers of muscle and fat, which makes blind injections particularly unreliable. Imaging guidance is essentially standard practice. A study evaluating ultrasound-guided hip injections found a 98% success rate on the first pass.²⁴ A systematic review found that imaging-guided corticosteroid injections in the hip were effective for both short- and long-term pain, and outperformed alternatives including hyaluronic acid, certain anesthetics, anti-inflammatory medications, and saline in terms of pain and function improvement.²⁵

The anterior approach (from the front of the hip) under ultrasound guidance has become widely favored because it avoids the neurovascular bundle that runs near the back of the joint. Fluoroscopy (real-time X-ray) is the traditional alternative and works well, but ultrasound has the advantage of being radiation-free and portable, making it practical in clinic settings.

Steroid Injections for Skin Conditions

Intralesional steroid injections for keloids and hypertrophic scars follow different rules than joint or muscle injections. The goal is to deliver medication directly into the scar tissue itself, not under it or too close to the skin surface. A scoping review of injection methods for keloids found that when the injection level was specified, researchers targeted the “body of the keloid” or “mid-lesion,” typically at a depth of 3-7 mm depending on lesion size. Several studies specifically warned against injecting under the keloid mass or too close to the outer skin layer, both of which increase the risk of local side effects.²⁶ For larger keloids, multiple injection points spaced about 1 cm apart were commonly used.

The side effects of intralesional steroid injections, including skin thinning, discoloration, and tissue atrophy, depend on the concentration, dose, depth, and location of the injection.²⁷ Injecting too superficially tends to cause more visible skin changes, while going too deep wastes medication by depositing it below the target tissue.

The Short-Term Pain Trap

Regardless of where a steroid is injected, one pattern shows up repeatedly across conditions: steroids tend to work well in the short term but sometimes lose their advantage or even reverse their benefit over longer periods. A large systematic review of tendon injections found that corticosteroid injections reduced pain significantly compared with other treatments in the short term, but this advantage reversed at intermediate and long-term follow-up. For lateral epicondylalgia (tennis elbow), the effect was dramatic: strong pain reduction early on, but patients who received no intervention actually did better at intermediate and long-term follow-up.²⁸

This does not mean steroid injections are useless for tendons, but it does mean that “best results” is not only about where the needle goes. The timing, the number of repeat injections, and whether the injection is paired with rehabilitation all shape the outcome. For joint osteoarthritis the calculus is different, since the goal is symptom management of an ongoing degenerative process rather than healing a tendon.

Post-Injection Flares

About one in five patients experiences a flare of pain after a musculoskeletal steroid injection, typically peaking within a day or two and lasting several days. A prospective study of 140 patients found that roughly 21% reported a pain flare, and younger age was the strongest predictor. Gender, injection location, BMI, and the type of corticosteroid used had no significant effect on flare risk.²⁹ A study focused on shoulder injections found a higher flare rate of about 35%, with symptoms lasting an average of four days.³⁰

Post-injection flares are caused by a crystal reaction to the steroid particles rather than by anything going wrong with needle placement. They are self-limiting and can be managed with ice and over-the-counter pain medication. Knowing that flares are common and temporary can prevent unnecessary anxiety or an unneeded trip back to the clinic. The real relief from the steroid itself typically kicks in within a few days to a week after the flare subsides.

Plantar Fasciitis and the Risk of Rupture

Steroid injections for plantar fasciitis present a specific concern: the plantar fascia is a thick band of tissue on the sole of your foot, and injecting corticosteroid into or near it carries a risk of rupture. Traditionally, these injections were done by feel, with the clinician pressing on the most tender spot and inserting the needle. Ultrasound guidance allows the clinician to place the injection accurately into the lesion rather than inadvertently damaging the fascia or injecting into surrounding soft tissue.³¹ This is one area where the “where” of the injection is not just about effectiveness but about avoiding a complication that could be worse than the original problem. A ruptured plantar fascia can lead to a collapsed arch and chronic foot pain.

If you’re offered a steroid injection for plantar fasciitis, asking whether it will be done under ultrasound guidance is a reasonable question. Not every facility has the equipment, but the trend in musculoskeletal medicine has been steadily moving toward image-guided injections for exactly these reasons. The injection itself typically targets the area of greatest thickening in the fascia, usually near where it attaches to the heel bone.